C4 Therapeutics Patents – Insights & Stats (Updated 2024)

C4 Therapeutics has a total of 273 patents globally, out of which 18 have been granted. Of these 273 patents, more than 83% patents are active. United States of America is where C4 Therapeutics has filed the maximum number of patents, followed by Europe (EPO) and China. Parallelly, United States of America seems to be the main focused R&D centre and also is the origin country of C4 Therapeutics.

C4 Therapeutics was founded in the year 2015. The Company operates as a biotechnology company. The Company focuses on novel early stage therapies that eliminate disease-causing proteins for the treatment of cancer, neurological and other diseases.

Do read about some of the most popular patents of C4 Therapeutics which have been covered by us in this article and also you can find C4 Therapeutics patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over C4 Therapeutics patent portfolio.

How many patents does C4 Therapeutics have?

C4 Therapeutics has a total of 273 patents globally. These patents belong to 50 unique patent families. Out of 273 patents, 229 patents are active.

How Many Patents did C4 Therapeutics File Every Year?

C4 Therapeutics Patent Filing Trend

Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.

Year of Patents Filing or GrantC4 Therapeutics Applications FiledC4 Therapeutics Patents Granted
2023247
2022585
2021783
2020503
201924
201822
201716

How many C4 Therapeutics patents are Alive/Dead?

C4 Therapeutics Patent Portfolio

 How Many Patents did C4 Therapeutics File in Different Countries?

C4 Therapeutics Worldwide Patent Filing

Countries in which C4 Therapeutics Filed Patents

CountryPatents
United States of America41
Europe (EPO)28
China28
Hong Kong (S.A.R.)24
Canada14
Taiwan12
Argentina11
Israel11
Australia10
New Zealand9
Singapore8
South Africa7
Mexico6
India6
Brazil4
Viet Nam3
Uruguay2
Indonesia2
Colombia2
Philippines1
Tunisia1
Chile1
Africa1
Peru1
Saudi Arabia1

Where are Research Centres of C4 Therapeutics Patents Located?

R&D Centers of C4 Therapeutics

10 Best C4 Therapeutics Patents

WO2017197051A1 is the most popular patent in the C4 Therapeutics portfolio. It has received 233 citations so far from companies like Arvinas, Inc., Kymera Therapeutics, Inc. and Goldfinch Bio, Inc.

Below is the list of 10 most cited patents of C4 Therapeutics:

Publication NumberCitation Count
WO2017197051A1233
WO2017197056A1200
WO2017197055A1130
WO2017197046A1126
WO2017197036A1102
WO2018237026A1100
US20190076539A157
WO2018115218A139
WO2018220149A138
WO2019191112A132

What Percentage of C4 Therapeutics US Patent Applications were Granted?

C4 Therapeutics (Excluding its subsidiaries) has filed 25 patent applications at USPTO so far (Excluding Design and PCT applications). Out of these 19 have been granted leading to a grant rate of 86.36%.

Below are the key stats of C4 Therapeutics patent prosecution at the USPTO.

Which Law Firms Filed Most US Patents for C4 Therapeutics?

Law FirmTotal ApplicationsSuccess Rate
Knowles Intellectual Property Strategies Llc2084.21%
Burns & Levinson Llp Dfci5100.00%

What are C4 Therapeutics key innovation segments?

What Technologies are Covered by C4 Therapeutics?

The chart below distributes patents filed by C4 Therapeutics in different countries on the basis of the technology protected in patents. It also represents the markets where C4 Therapeutics thinks it’s important to protect particular technology inventions.

R&D Focus: How has C4 Therapeutics search focus changed over the years?

EXCLUSIVE INSIGHTS COMING SOON!

Interested in knowing about the areas of innovation that are being protected by C4 Therapeutics?

Related Articles

Leave a Comment

Fill the form to get the details:

Fill the form to get the details:

Our comprehensive report provides an in-depth look into the patent portfolio. The report includes a breakdown of the patent portfolio across various technologies, listing the patent along with brief summaries of each patent's technology.